Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

August 31, 2009

Conditions
Oral CavitySquamous Cell Carcinoma
Interventions
DRUG

cisplatin

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

collaborator

Changhua Christian Hospital

OTHER

collaborator

China Medical University Hospital

OTHER

collaborator

Buddhist Tzu Chi General Hospital

OTHER

collaborator

Mackay Memorial Hospital

OTHER

collaborator

Koo Foundation Sun Yat-Sen Cancer Center

OTHER

collaborator

Chi Mei Medical Hospital

OTHER

collaborator

Kaohsiung Veterans General Hospital.

OTHER

lead

National Health Research Institutes, Taiwan

OTHER

NCT00201383 - Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients | Biotech Hunter | Biotech Hunter